PeptideDB

L524-0366

CAS No.: 951612-19-4

L524-0366 ([1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone) is a TWEAK-Fn14 signaling cascade inhibitor.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description L524-0366 ([1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone) is a TWEAK-Fn14 signaling cascade inhibitor.
In vitro L524-0366通过TAC减轻了不良重塑。TWEAK通过部分激活非典型NF-κB信号传导,诱导了来自WT但不是Fn14-/-纤维细胞的促炎症趋化因子,单核细胞趋化蛋白1的分泌。最终,在TAC后的小鼠以及人类衰竭心脏中,发现Fn14表达增加。
Cell experiments Wild type (WT) and Fn14 knock out (Fn14-/-) mice were subjected to pressure overload [transaortic constriction (TAC)] for 1 or 6 weeks. A subset of WT TAC animals were treated with the Fn14 antagonist L524-0366. Cardiac function was measured by echocardiography. Cardiac fibrosis and macrophage infiltration were quantified using immunohistochemistry and flow cytometry, respectively. Cardiac fibroblasts were isolated for quantifying TWEAK-induced chemokine release.
Synonyms [1-(3-chlorophenyl)triazol-4-yl]-thiomorpholino-methanone
molecular weight 308.79
Molecular formula C13H13ClN4OS
CAS 951612-19-4
Storage keep away from direct sunlight|Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 25 mg/ml (80.96 mM), Sonication is recommended.
References 1. Unudurthi S D , Nassal D M , Patel N J , et al. Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction[J]. Life ences, 2020, 247:117440.
Citations 1. Li Z, Wang H, Zhu J, et al. Inhibition of TWEAK/Tnfrsf12a axis protects against acute liver failure by suppressing RIPK1-dependent apoptosis. Cell Death Discovery. 2022, 8(1): 1-11